Western blot analysis of tumor lysates showed effective inhibition of p-FAK (Y397) at 75 mg/kg VS4718, and p-ERK (T202/Y204) at 0.5 mg/kg a trametinib (Supplementary Figure S4). This evidence concerns the gene PTK2 and neoplasm.